Trial Profile
Efficacy of Ranibizumab Therapy With Aflibercept in Patients With Diabetic Macular Edema
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Feb 2016
Price :
$35
*
At a glance
- Drugs Aflibercept (Primary) ; Ranibizumab (Primary)
- Indications Diabetic macular oedema
- Focus Therapeutic Use
- 11 Jan 2016 New trial record